Synopsys, Inc. $SNPS Stock Holdings Increased by Exchange Traded Concepts LLC

Exchange Traded Concepts LLC grew its position in shares of Synopsys, Inc. (NASDAQ:SNPS) by 68.1% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,705 shares of the semiconductor company’s stock after buying an additional 1,501 shares during the period. Exchange Traded Concepts LLC’s holdings in Synopsys were worth $1,828,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in SNPS. Riverbridge Partners LLC acquired a new stake in shares of Synopsys during the 3rd quarter valued at approximately $26,683,000. CCLA Investment Management raised its holdings in shares of Synopsys by 4.7% during the third quarter. CCLA Investment Management now owns 322,430 shares of the semiconductor company’s stock worth $159,093,000 after purchasing an additional 14,463 shares during the period. Legacy Wealth Asset Management LLC acquired a new stake in shares of Synopsys during the third quarter worth $1,498,000. Salvus Wealth Management LLC bought a new position in shares of Synopsys in the 3rd quarter worth about $323,000. Finally, Sound Income Strategies LLC boosted its holdings in shares of Synopsys by 822.7% in the 3rd quarter. Sound Income Strategies LLC now owns 203 shares of the semiconductor company’s stock valued at $98,000 after buying an additional 181 shares during the period. Institutional investors and hedge funds own 85.47% of the company’s stock.

Insider Buying and Selling

In other Synopsys news, CFO Shelagh Glaser sold 3,657 shares of the business’s stock in a transaction dated Friday, December 19th. The shares were sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the sale, the chief financial officer directly owned 17,842 shares in the company, valued at approximately $8,221,058.34. The trade was a 17.01% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.62% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on the stock. Wells Fargo & Company increased their price objective on shares of Synopsys from $445.00 to $500.00 and gave the stock an “equal weight” rating in a research note on Thursday, December 11th. Piper Sandler dropped their price target on Synopsys from $630.00 to $602.00 and set an “overweight” rating on the stock in a research report on Thursday, December 11th. Morgan Stanley raised their price target on Synopsys from $510.00 to $550.00 and gave the stock an “overweight” rating in a report on Friday, December 12th. Wall Street Zen upgraded Synopsys from a “sell” rating to a “hold” rating in a research note on Saturday, December 13th. Finally, The Goldman Sachs Group dropped their target price on Synopsys from $700.00 to $600.00 and set a “buy” rating on the stock in a research report on Wednesday, September 10th. Eleven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $562.13.

Key Headlines Impacting Synopsys

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Analysts/commentary note Synopsys’ recent bounce and argue the shares could be attractive after the pullback; these narratives can support buying interest as investors re-evaluate valuation and growth prospects. Is Synopsys (SNPS) an Attractive Investment Choice?
• Positive Sentiment: Separate coverage focuses on an ~18% share rebound, asking whether the recovery leaves the stock undervalued — this kind of coverage can support momentum buyers. Synopsys (SNPS): Has the Recent 18% Share Price Rebound Left the Stock Undervalued?
• Neutral Sentiment: Reported short-interest data appears to show a 0-share figure and 0.0 days-to-cover — likely a data glitch and not a reliable signal for positioning. Treat this as non-actionable until confirmed by an exchange/shorts report.
• Negative Sentiment: Multiple law firms have announced class-action suits or investor alerts alleging securities fraud tied to a sharp prior stock drop; firms are soliciting lead plaintiffs with a looming Dec. 30, 2025 deadline. The alleged class period is Dec. 4, 2024 through Sept. 9, 2025; some filings cite a ~36% decline as the basis for claims. This concentrated legal publicity increases headline risk, potential litigation costs, and investor uncertainty — factors that can pressure the stock. Representative notices: KSF / Charles Foti 96-Hour Deadline Alert — BFA: Suit after 36% stock drop — Levi & Korsinsky notice

Synopsys Stock Up 0.3%

SNPS opened at $477.14 on Friday. The stock’s 50 day moving average price is $437.58 and its 200 day moving average price is $503.61. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.62 and a quick ratio of 1.52. The stock has a market cap of $91.29 billion, a P/E ratio of 59.72, a P/E/G ratio of 3.96 and a beta of 1.16. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $651.73.

Synopsys (NASDAQ:SNPS) last released its quarterly earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.79 by $0.11. Synopsys had a return on equity of 7.89% and a net margin of 18.89%.The company had revenue of $2.25 billion during the quarter, compared to analysts’ expectations of $2.25 billion. During the same quarter in the prior year, the business posted $3.40 earnings per share. The company’s revenue for the quarter was up 37.8% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. As a group, research analysts predict that Synopsys, Inc. will post 10.64 earnings per share for the current year.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.